Background: The prevalence of Substance Use Disorder (SUD) is increasing along with the
need to develop approaches to reduce the harm associated with substance use, including …

Background The prevalence of cannabis use and cannabis use disorders (CUD) has
significantly increased over time. However, there are no approved pharmacological …

Substance-use disorders are pervasive, comorbid with a plethora of disease and possess
limited treatment options. Medicinal cannabinoids have been proposed as a novel potential …

Introduction Patients and healthcare practitioners are increasingly interested in using
cannabis and cannabinoids to address unmet clinical needs. Although we have clinical …

Background: Cannabidiol (CBD) is a cannabinoid of potential interest for the treatment of
substance use disorders. Our aim was to review the outcome measures, surrogate …

Importance Cannabis and cannabinoid drugs are widely used to treat disease or alleviate
symptoms, but their efficacy for specific indications is not clear. Objective To conduct a …

Purpose of review There have been many debates, discussions, and published writings
about the therapeutic value of cannabis plant and the hundreds of cannabinoids it contains …

Purpose This systematic review assesses currently available clinical information on which
cannabinoids and what range of doses have been used to achieve positive effects in a …

• Studies designed as randomized controlled trials (RCTs) are intended to produce high-
quality evidence and are crucial tools in the assessment of medical cannabis and …

Objective The drug poisoning crisis throughout North America necessitates novel harm
reduction approaches. Emerging evidence suggests that cannabidiol (CBD) may have some …